Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions

References

• Almaghrabi OA. (2015). Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi J Biol Sci 22:227–31.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Mitragotri S. (2017). Intestinal patch systems for oral drug delivery. Curr Opin Pharmacol 36:58–65.
   PubMed Web of Science ®Google Scholar
• Bhardwaj RK, Glaeser H, Becquemont L, et al. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302:645–50.
   PubMed Web of Science ®Google Scholar
• Bhattaram VA, Graefe U, Fau-Kohlert C, Kohlert C, Fau-Veit  , et al. (2002). Pharmacokinetics and bioavailability of herbal medicinal products. Phytomed: Int J Phytotherapy Phytopharmacol 9:1–33.
   PubMed Web of Science ®Google Scholar
• Bi X, Yuan Z, Qu B, et al. (2019). Piperine enhances the bioavailability of silybin via inhibition of efflux transporters BCRP and MRP2. Phytomedicine 54:98–108.
   PubMed Web of Science ®Google Scholar
• Boots AW, Haenen GRMM, Bast A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–37.
   PubMed Web of Science ®Google Scholar
• Cai X, Fang Z, Dou J, et al. (2013). Bioavailability of quercetin: problems and promises. Curr Med Chem 20:2572–82.
   PubMed Web of Science ®Google Scholar
• Day AJ, Mellon F, Barron D, et al. (2001). Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35:941–52.
   PubMed Web of Science ®Google Scholar
• Dong D, Quan E, Yuan X, et al. (2017). Sodium oleate-based nanoemulsion enhances oral absorption of chrysin through inhibition of UGT-mediated metabolism. Mol Pharm 14:2864–74.
   PubMed Web of Science ®Google Scholar
• Fasolo D, Schwingel L, Fau-Holzschuh M, Holzschuh M, Fau-Bassani  , et al. (2007). Validation of an isocratic LC method for determination of quercetin and methylquercetin in topical nanoemulsions. J Pharm Biomed Anal 44:1174–7.
   PubMed Web of Science ®Google Scholar
• Federica L, Rosario J, Carmen M, et al. (2008). Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. Planta Med 74:741–6.
   PubMed Web of Science ®Google Scholar
• Federica L, Rosario J, Laura M, et al. (2009). Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 204:34–9.
   PubMed Web of Science ®Google Scholar
• Guzy J, Kusnír J, Mareková M, et al. (2003). Effect of quercetin on daunorubicin-induced heart mitochondria changes in rats. Physiol Res 52:773–80.
   PubMed Web of Science ®Google Scholar
• Hussain N, Jaitley V, Florence AT. (2001). Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50:107–42.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang ZH, Sun E, et al. (2013). Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies. Int J Nanomedicine 8:641–52.
   PubMed Web of Science ®Google Scholar
• Justino GC, Santos MR, Canário S, et al. (2004). Plasma quercetin metabolites: structure-antioxidant activity relationships. Arch Biochem Biophys 432:109–21.
   PubMed Web of Science ®Google Scholar
• Kale R, Saraf M, Juvekar A, Tayade P. (2006). Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system. J Pharm Pharmacol 58:1351–8.
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Pakade YB, et al. (2010). Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B Biointerfaces 80:184–92.
   PubMed Web of Science ®Google Scholar
• Lan H, Hong W, Fan P, et al. (2017). Quercetin inhibits cell migration and invasion in human osteosarcoma cells. Cell Physiol Biochem 43:553–67.
   PubMedGoogle Scholar
• Larson AJ, David SJ, Thunder J. (2012). Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr 3:39–46.
   PubMed Web of Science ®Google Scholar
• Lei CS, Hou YC, Pai MH, et al. (2018). Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studies. J Nutr Biochem 51:105–13.
   PubMed Web of Science ®Google Scholar
• Li H, Zhao X, Ma Y, et al. (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133:238–44.
   PubMed Web of Science ®Google Scholar
• Liao YR, Lin JY. (2014). Quercetin, but not its metabolite quercetin-3-glucuronide, exerts prophylactic immunostimulatory activity and therapeutic antiinflammatory effects on lipopolysaccharide-treated mouse peritoneal macrophages ex vivo. J Agric Food Chem 62:2872–80.
   PubMed Web of Science ®Google Scholar
• Ma T, Liu Y, Wu Q, et al. (2019). Quercetin-modified metal-organic frameworks for dual sensitization of radiotherapy in tumor tissues by inhibiting the carbonic anhydrase IX. ACS Nano 13:4209–19.
   PubMed Web of Science ®Google Scholar
• Macierzanka A, Rigby NM, Corfield AP, et al. (2011). Adsorption of bile salts to particles allows penetration of intestinal mucus. Soft Matter 7:8077–84.
   Web of Science ®Google Scholar
• Mei L, Zhang Z, Zhao L, et al. (2013). Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev 65:880–90.
   PubMed Web of Science ®Google Scholar
• Menendez C, Dueñas M, Galindo P, et al. (2011). Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? Mol Nutr Food Res 55:1780–90.
   PubMed Web of Science ®Google Scholar
• Mullen W, Edwards CA, Crozier A. (2006). Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96:107–16.
   PubMed Web of Science ®Google Scholar
• Nait Chabane M, Al Ahmad A, Peluso J, et al. (2009). Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 61:1473–83.
   PubMed Web of Science ®Google Scholar
• Perez A, Gonzalez-Manzano S, Jimenez R, et al. (2014). The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol Res 89:11–8.
   PubMed Web of Science ®Google Scholar
• Rauf A, Imran M, Khan IA, et al. (2018). Anticancer potential of quercetin: a comprehensive review. Phytother Res 32:2109–30.
   PubMed Web of Science ®Google Scholar
• Shahidi F, Ambigaipalan P. (2015). Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects – a review. J Funct Foods 18:820–97.
   Web of Science ®Google Scholar
• Sigfridsson K, Lundqvist AJ, Strimfors M. (2009). Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development. Drug Dev Ind Pharm 35:1479–86.
   PubMed Web of Science ®Google Scholar
• Simioni C, Zauli G, Martelli AM, et al. (2018). Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. Oncotarget 9:17181–98.
   PubMedGoogle Scholar
• Tao SL, Desai TA. (2005). Gastrointestinal patch systems for oral drug delivery. Drug Discov Today 10:909–15.
   PubMed Web of Science ®Google Scholar
• Volak LP, Ghirmai S, Cashman JR, Court MH. (2008). Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos 36:1594–605.
   PubMed Web of Science ®Google Scholar
• Waterman KC, Sutton SC. (2003). A computational model for particle size influence on drug absorption during controlled-release colonic delivery. J Controlled Release: Off J Controlled Release Soc 86:293–304.
   PubMed Web of Science ®Google Scholar
• Williamson G, Manach C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81:243S–55s.
   PubMed Web of Science ®Google Scholar
• Wu T, Yen F, Lin L, et al. (2008). Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm 346:160–8.
   PubMed Web of Science ®Google Scholar
• Xiao C, Yin OQP, Zhong Z, Chow MSS. (2005). Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 22:892–901.
   PubMed Web of Science ®Google Scholar
• Yao X, Zhou G, Tang Y, et al. (2013). A UPLC-MS/MS method for qualification of quercetin-3-O-β-D-glucopyranoside-(4→1)-α-L-rhamnoside in rat plasma and application to pharmacokinetic studies. Molecules 18:3050–9.
   PubMed Web of Science ®Google Scholar
• Yuan H, Chen CY, Chai GH, et al. (2013). Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm 10:1865–73.
   PubMed Web of Science ®Google Scholar
• Zhang T, Dong D, Lu D, et al. (2016). Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells. Int J Pharm 501:190–8.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou M, Yang FF, et al. (2015). Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. Mol Pharm 12:1084–95.
   PubMed Web of Science ®Google Scholar
• Zhu D, Tao W, Zhang H, et al. (2016). Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater 30:144–54.
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. (2014). Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials 35:2391–400.
   PubMed Web of Science ®Google Scholar